TrialDiabetes, obesity & metabolism2015

Lobeglitazone and pioglitazone as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, parallel-group, active-controlled, phase III clinical trial with a 28-week extension.

S-M Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.